Replies to post #88744 on Ocata Therapeutics Inc fka OCAT

[farviewhill]

If I may suggest a different perspective, 2019 is not the focus at all, but upcoming clinical efficacy and 2016 are DEFINITELY where it's at.
A noted, that's when if the clinical sun is shining, the 'Pfizers' and Mutual Fund managers of the world open their wallets and buy, buy.
Or as noted, if not, back to our utilities and 'GE's'.